Revive Therapeutics Ltd (RVV.CN)
0.0100 +0.0050 (+100.00%) 03/17/25 [CNSX]
0.0050 x 15,613,000 0.0100 x 1,066,000
Realtime by (Cboe BZX)
0.0050 x 15,613,000 0.0100 x 1,066,000
Realtime - - (-) -
for Mon, Mar 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
(Values in thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55 | 273 | 773 | 1,049 | 708 |
| Receivables | 1 | 13 | 21 | 116 | 138 |
| Other current assets | 20 | 20 | 50 | 50 | 50 |
| TOTAL | $202 | $529 | $1,141 | $1,293 | $991 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 1 |
| Investments And Advances | 134 | 140 | 116 | 126 | 163 |
| Intangibles | 9,378 | 9,378 | 9,378 | 11,723 | 11,723 |
| TOTAL | $9,513 | $9,519 | $9,495 | $11,850 | $11,887 |
| Total Assets | $9,715 | $10,048 | $10,636 | $13,143 | $12,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,571 | 2,572 | 2,580 | 2,543 | 2,491 |
| Accrued Expenses | 666 | 638 | 718 | 641 | 621 |
| TOTAL | $3,238 | $3,210 | $3,324 | $3,246 | $3,208 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 60 |
| aiOther Non-Current Liabilities | 83 | 79 | 80 | 80 | 78 |
| TOTAL | $83 | $79 | $80 | $80 | $138 |
| Total Liabilities | $3,321 | $3,289 | $3,404 | $3,325 | $3,346 |
| Shareholders' Equity | |||||
| Common Shares | 47,500 | 47,500 | 47,500 | 47,500 | 46,020 |
| Retained earnings | -67,024 | -66,659 | -66,186 | -63,601 | -61,729 |
| Other shareholders' equity | 2,408 | 2,408 | 2,408 | 2,408 | 12,584 |
| TOTAL | $6,395 | $6,759 | $7,232 | $9,817 | $9,531 |
| Total Liabilities And Equity | $9,715 | $10,048 | $10,636 | $13,143 | $12,877 |